Drude N, Nagel-Riedasch S, Rosshart SP, Diefenbach A; “Charité 3R Wildling Mouse Model in Health and Disease (C3R Wildling HeaD)” consortium; 2024. A facility for laboratory mice with a natural microbiome at Charité – Universitätsmedizin Berlin. Jordan S.Lab Anim (NY). 53(12):351-354. doi: 10.1038/s41684-024-01474-4.
Bruno P, Schüler T, Rosshart SP. 2024. Born to be wild: utilizing natural microbiota for reliable biomedical research. Trends Immunol. 46(1):17-28. doi: 10.1016/j.it.2024.11.013.
Ankerhold J, Kessler S, Beer M, Schwemmle M, Ciminski K. 2025. Replication Restriction of Influenza A(H5N1) Clade 2.3.4.4b Viruses by Human Immune Factor, 2023-2024. Emerg Infect Dis. Jan;31(1):199-202. doi: 10.3201/eid3101.241236.
Wang Y, Hess ME, Tan Y, Esser PR, Nyström A, Boerries M, Sayar SB, Has C. 2025. Alterations in the microenvironment of junctional epidermolysis bullosa keratinocytes: A gene expression study. Matrix Biol. 35:12-23. doi: 10.1016/j.matbio.2024.11.005.
Kiritsi D, Schauer F, Gewert S, Reineker K, Reimer-Taschenbrecker A, Schwieger-Briel A, Ott H, Schmoor C, Grishina O, Murrell D, Stiller B, Zahn T, Nyström A, Bruckner-Tuderman L. 2024. Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trial. EClinicalMedicine. 2024 Oct 30;77:102900. doi: 10.1016/j.eclinm.2024.102900.
Saller BS, Wöhrle S, Fischer L, Dufossez C, Ingerl IL, Kessler S, Mateo-Tortola M, Gorka O, Lange F, Cheng Y, Neuwirt E, Marada A, Koentges C, Urban C, Aktories P, Reuther P, Giese S, Kirschnek S, Mayer C, Pilic J, Falquez-Medina H, Oelgeklaus A, Deepagan VG, Shojaee F, Zimmermann JA, Weber D, Tai YH, Crois A, Ciminski K, Peyronnet R, Brandenburg KS, Wu G, Baumeister R, Heimbucher T, Rizzi M, Riedel D, Helmstädter M, Buescher J, Neumann K, Misgeld T, Kerschensteiner M, Walentek P, Kreutz C, Maurer U, Rambold AS, Vince JE, Edlich F, Malli R, Häcker G, Kierdorf K, Meisinger C, Köttgen A, Jakobs S, Weber ANR, Schwemmle M, Groß CJ, Groß O. 2024. Acute suppression of mitochondrial ATP production prevents apoptosis and provides an essential signal for NLRP3 inflammasome activation. Immunity. S1074-7613(24)00492-8. doi: 10.1016/j.immuni.2024.10.012.
Mann J, Runge S, Schell C, Gräwe K, Thoulass G, Lao J, Ammann S, Grün S, König C, Berger SA, Hild B, Aichele P, Rosshart SP, Ehl S. 2024. The Microbiome Modifies Manifestations of Hemophagocytic Lymphohistiocytosis in Perforin-Deficient Mice. Eur J Immunol. 2024 Nov 16:e202451061. doi: 10.1002/eji.202451061.
Giesler S, Riemer R, Lowinus T, Zeiser R. 2024. Immune-mediated colitis after immune checkpoint inhibitor therapy. Trends Mol Med. 2024 Oct 29:S1471-4914(24)00266-1. doi: 10.1016/j.molmed.2024.09.009.
Vogele D, Wöhrle S, Saller BS, Fröhlich K, Barta BA, Cosenza-Contreras M, Groß O, Schilling O. 2024. Size exclusion chromatography based proteomic and degradomic profiling of inflammasome-activated, murine bone marrow-derived dendritic cells highlights complex retention and release of cleavage products. Mol Omics. 2024 Oct 28;20(9):595-610. doi: 10.1039/d4mo00163j.
Minguet S, Maus MV, Schamel WW. 2024. From TCR fundamental research to innovative chimeric antigen receptor design. Nat Rev Immunol. 2024 Oct 21. doi: 10.1038/s41577-024-01093-7.
Hofmann M, Thimme R, Schamel WW. 2024. PD-1 and LAG-3: synergistic fostering of T cell exhaustion. Signal Transduct Target Ther. 2024 Oct 18;9(1):291. doi: 10.1038/s41392-024-02000-1.
Salié H, Wischer L, D’Alessio A, Godbole I, Suo Y, Otto-Mora P, Beck J, Neumann O, Stenzinger A, Schirmacher P, Fulgenzi CAM, Blaumeiser A, Boerries M, Roehlen N, Schultheiß M, Hofmann M, Thimme R, Pinato DJ, Longerich T, Bengsch B. 2024. Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma. Gut. Oct 14:gutjnl-2024-332837. doi: 10.1136/gutjnl-2024-332837.
Geiger RA, Khera D, Tenthorey JL, Kochs G, Graf L, Emerman M, Malik HS. 2024. Heterozygous and generalist MxA super-restrictors overcome breadth-specificity tradeoffs in antiviral restriction. bioRxiv [Preprint]. 2024 Oct 10:2024.10.10.617484. doi: 10.1101/2024.10.10.617484.
Dumas AA, Dalmau Gasull A, Prinz M. 2024. Beyond borders: the choroid plexus-immune communication during neuroinflammation. Signal Transduct Target Ther. 2024 Oct 8;9(1):278. doi: 10.1038/s41392-024-01997-9.
Wenger V, Zeiser R. 2024. Deciphering the role of the major histocompatibility complex, the intestinal microbiome and metabolites in the pathogenesis of acute graft-versus-host disease. Best Pract Res Clin Haematol. 2024 Sep;37(3):101567. doi: 10.1016/j.beha.2024.101567.
Contact
Scientific Manager/Administration
Dr. Heike Ufheil
Institute for Immunodeficiency,
Center for Chronic Immunodeficiency (CCI)
Medical Center – University of Freiburg
